Adjuvant treatment with tamoxifen. Recruitment into studies assessing optimum duration of treatment must continue.
Earl
H
H
Baker
P
P
Kerr
D
D
Lee
M
M
Gray
R
R
Baum
M
M
D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D013629:Tamoxifen / Q000009:adverse effects*; D013997:Time Factors
D018931:Antineoplastic Agents, Hormonal; D013629:Tamoxifen